Correlation Between Pieris Pharmaceuticals and Nabriva Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pieris Pharmaceuticals and Nabriva Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pieris Pharmaceuticals and Nabriva Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pieris Pharmaceuticals and Nabriva Therapeutics AG, you can compare the effects of market volatilities on Pieris Pharmaceuticals and Nabriva Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pieris Pharmaceuticals with a short position of Nabriva Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pieris Pharmaceuticals and Nabriva Therapeutics.

Diversification Opportunities for Pieris Pharmaceuticals and Nabriva Therapeutics

0.02
  Correlation Coefficient

Significant diversification

The 3 months correlation between Pieris and Nabriva is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Pieris Pharmaceuticals and Nabriva Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nabriva Therapeutics and Pieris Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pieris Pharmaceuticals are associated (or correlated) with Nabriva Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nabriva Therapeutics has no effect on the direction of Pieris Pharmaceuticals i.e., Pieris Pharmaceuticals and Nabriva Therapeutics go up and down completely randomly.

Pair Corralation between Pieris Pharmaceuticals and Nabriva Therapeutics

If you would invest  975.00  in Pieris Pharmaceuticals on August 25, 2024 and sell it today you would earn a total of  702.00  from holding Pieris Pharmaceuticals or generate 72.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy0.79%
ValuesDaily Returns

Pieris Pharmaceuticals  vs.  Nabriva Therapeutics AG

 Performance 
       Timeline  
Pieris Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pieris Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
Nabriva Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nabriva Therapeutics AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Nabriva Therapeutics is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pieris Pharmaceuticals and Nabriva Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pieris Pharmaceuticals and Nabriva Therapeutics

The main advantage of trading using opposite Pieris Pharmaceuticals and Nabriva Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pieris Pharmaceuticals position performs unexpectedly, Nabriva Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nabriva Therapeutics will offset losses from the drop in Nabriva Therapeutics' long position.
The idea behind Pieris Pharmaceuticals and Nabriva Therapeutics AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk